Rush Street Interactive 주식 (NYSE: RSI)

Rush Street Interactive (NYSE:RSI) 주식

RUSH STREET INTERACTIVE INC

Rush Street Interactive

Rush Street Interactive Inc is an online gaming and entertainment company that focuses on online casinos and online sports betting in the U.S. and Latin American markets. It provides customers with an array of gaming offerings such as real-money online casinos, online sports betting, and retail sports betting, as well as social gaming, which involves free-to-play games that use virtual credits that can be earned or purchased. The company generates revenue by offering online casinos, online sports betting, and social gaming directly to the end customer through its websites or apps. The company generates revenue through business-to-consumer (B2C) and business-to-business (B2B) models.

Rush Street Interactive, Inc. Class A Common Stock

Rush Street Interactive Inc

RASA INDUSTRIES LTD by RASA INDUSTRIES LTD.

Rasa Industries Ltd

RESET IV INC by RESET IV INC

ARB IOT Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARBB#NASDAQ">ARBB</a>, the ", Company", or "ARB IOT"))), today announced that the shareholders and the board of directors of the Company approved a one-for-fifteen reverse share split of the Company's issued and unissued ordinary shares (the "Ordinary Shares"). Beginning June 2, 2025, the Company's Ordinary Shares will be trading on a split-adjusted basis under the same symbol "ARBB" but with a new CUSIP number, G0447T118, and a new par value of $0.0015 per share.
As a result of the reverse share split, each fifteen Ordinary Shares outstanding will automatically combine and convert to one issued and outstanding Ordinary Share without any action on the part of shareholders who hold their shares in brokerage accounts or "street name." Shareholders holding certificates of Ordinary Shares are expected to receive instructions from the Company's transfer agent, Vstock Transfer, LLC, regarding procedures for exchanging share certificates. All outstanding warrants to purchase the Company's Ordinary Shares will be adjusted proportionately as a result of the reverse share split. No fractional shares will be issued as a result of the reverse share split, and instead, all such fractional shares resulting from the reverse share split will be rounded up to the nearest whole share.
The reverse share split is intended to increase the per share trading price of the Ordinary Shares to satisfy the $1.00 minimum bid price requirement for continued listing on the NASDAQ Stock Market. Following the reverse share split, the Company will have approximately 1,765,276 Ordinary Shares issued and outstanding, exclusive of shares issuable under outstanding warrants, and the Company will have 33,333,333 authorized Ordinary Shares.

News

Stock Split

ARBB

ARB IOT Group Board Approves 1-For-15 Reverse Share Split Issued And Unissued Ordinary Shares

Bernstein analyst Peter Weed maintains SentinelOne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/S#NYSE">S</a>) with a Outperform and lowers the price target from $27 to $25.

Price Target

Analyst Ratings

Bernstein Maintains Outperform on SentinelOne, Lowers Price Target to $25

Super League Enterprise, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLE#NASDAQ">SLE</a>) (the "Company"), a leader in redefining how brands connect with consumers through the power of playable media, today announced the pricing of a firm commitment underwritten public offering with gross proceeds to the Company expected to be approximately $500,000, before deducting underwriting fees and other offering expenses payable by the Company.
The offering consists of 4,166,666 shares of common stock. The public offering price per share of common stock is $0.12. In addition, the Company has granted the underwriter an overallotment option to purchase up to an additional 416,666 shares of common stock, which option is exercisable in whole or in part at any time up to 45 days after the date of this prospectus.
Aggregate gross proceeds to the Company are expected to be approximately $500,000, or $550,000 if the over allotment option is exercised in full. The transaction is expected to close on or about May 30, 2025, subject to the satisfaction of customary closing conditions. The Company expects to use the net proceeds from the offering, together with its existing cash, for general corporate purposes and working capital and the repayment of a portion of the Company's indebtedness.

Offerings

Super League Enterprise Announces $500,000 Underwritten Public Offering Of 4.17M Shares At A Price Of $0.12 Per Share

Buybacks

TRUG

TruGolf Holdings Announces It Will Seek Shareholder Approval To Repurchase $2M Of Its Common Stock

<h3>Gainers</h3>
<ul>
<li>Greenlane Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) stock increased by 33.3% to $0.01 during Thursday's pre-market session. The market value of their outstanding shares is at $7.7 million. </li>
<li>Build-A-Bear Workshop (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBW#NYSE">BBW</a>) shares increased by 16.87% to $50.0. The market value of their outstanding shares is at $657.2 million. The company's, Q1 earnings came out today. </li>
<li>Jinxin Technology Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAMI#NASDAQ">NAMI</a>) shares moved upwards by 16.02% to $3.33. The company's market cap stands at $227.6 million. </li>
<li>Ballys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BALY#NYSE">BALY</a>) stock moved upwards by 13.63% to $11.75. The company's market cap stands at $575.9 million. </li>
<li>Springview Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPHL#NASDAQ">SPHL</a>) shares increased by 9.52% to $0.57. The market value of their outstanding shares is at $6.5 million. </li>
<li>Yatra Online (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YTRA#NASDAQ">YTRA</a>) shares moved upwards by 8.34% to $0.98. The market value of their outstanding shares is at $58.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>NWTN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWTN#NASDAQ">NWTN</a>) stock fell 14.2% to $1.93 during Thursday's pre-market session. The market value of their outstanding shares is at $552.3 million. </li>
<li>LiveWire Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LVWR#NYSE">LVWR</a>) stock declined by 13.61% to $3.43. The market value of their outstanding shares is at $698.2 million. </li>
<li>Allied Gaming (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGAE#NASDAQ">AGAE</a>) shares declined by 9.22% to $3.1. The market value of their outstanding shares is at $136.9 million. </li>
<li>Caleres (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAL#NYSE">CAL</a>) stock fell 5.56% to $15.47. The company's market cap stands at $519.9 million. The company's, Q1 earnings came out today. </li>
<li>QVC Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QVCGA#NASDAQ">QVCGA</a>) shares decreased by 4.85% to $4.32. The company's market cap stands at $34.8 million. </li>
<li>Lulus Fashion Lounge (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LVLU#NASDAQ">LVLU</a>) stock fell 4.66% to $0.41. The company's market cap stands at $17.6 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

AGAE

BALY

GNLN

LVLU

LVWR

NAMI

NWTN

QVCGA

SPHL

YTRA

12 Consumer Discretionary Stocks Moving In Thursday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Healthcare Triangle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCTI#NASDAQ">HCTI</a>) stock increased by 93.1% to $0.01 during Thursday's pre-market session. The market value of their outstanding shares is at $4.5 million. </li>
<li>NanoVibronix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAOV#NASDAQ">NAOV</a>) shares increased by 50.77% to $1.29. The company's market cap stands at $3.3 million. </li>
<li>Alzamend Neuro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALZN#NASDAQ">ALZN</a>) shares rose 27.59% to $4.24. The company's market cap stands at $3.1 million. </li>
<li>ORIC Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORIC#NASDAQ">ORIC</a>) shares increased by 21.94% to $7.28. The company's market cap stands at $517.4 million. </li>
<li>Imunon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMNN#NASDAQ">IMNN</a>) stock moved upwards by 21.05% to $1.84. The market value of their outstanding shares is at $32.2 million. </li>
<li>Taysha Gene Therapies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSHA#NASDAQ">TSHA</a>) stock moved upwards by 17.62% to $2.87. The market value of their outstanding shares is at $616.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Revelation Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REVB#NASDAQ">REVB</a>) stock decreased by 52.6% to $0.91 during Thursday's pre-market session. </li>
<li>Rapport Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAPP#NASDAQ">RAPP</a>) stock decreased by 25.07% to $7.13. The market value of their outstanding shares is at $260.0 million. </li>
<li>Intellia Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTLA#NASDAQ">NTLA</a>) shares decreased by 20.81% to $7.65. The market value of their outstanding shares is at $792.4 million. </li>
<li>Aspire Biopharma Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASBP#NASDAQ">ASBP</a>) stock decreased by 18.78% to $0.57. The market value of their outstanding shares is at $28.4 million. </li>
<li>CollPlant Biotechnologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLGN#NASDAQ">CLGN</a>) stock declined by 15.0% to $2.89. The company's market cap stands at $33.1 million. As per the news, the Q1 earnings report came out yesterday. </li>
<li>bioAffinity Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIAF#NASDAQ">BIAF</a>) stock declined by 9.76% to $0.36. The market value of their outstanding shares is at $9.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ALZN

ASBP

BIAF

CLGN

HCTI

IMNN

NAOV

NTLA

ORIC

RAPP

REVB

TSHA

12 Health Care Stocks Moving In Thursday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Zeo Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZEO#NASDAQ">ZEO</a>) stock rose 108.9% to $3.3 during Thursday's pre-market session. The company's market cap stands at $46.3 million. The company's, Q4 earnings came out 2 days ago. </li>
<li>VCI Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VCIG#NASDAQ">VCIG</a>) shares moved upwards by 50.52% to $4.29. The company's market cap stands at $15.3 million. </li>
<li>Captivision (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAPT#NASDAQ">CAPT</a>) shares moved upwards by 16.36% to $0.74. The company's market cap stands at $24.1 million. </li>
<li>Graphjet Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTI#NASDAQ">GTI</a>) stock moved upwards by 12.65% to $0.15. The market value of their outstanding shares is at $22.0 million. </li>
<li>Richtech Robotics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RR#NASDAQ">RR</a>) stock moved upwards by 10.66% to $2.8. The company's market cap stands at $321.4 million. </li>
<li>Fusion Fuel Green (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTOO#NASDAQ">HTOO</a>) stock moved upwards by 8.14% to $0.3. The market value of their outstanding shares is at $8.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Elong Power Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELPW#NASDAQ">ELPW</a>) shares fell 61.4% to $1.35 during Thursday's pre-market session. The market value of their outstanding shares is at $67.5 million. </li>
<li>Eos Energy Enterprises (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EOSE#NASDAQ">EOSE</a>) shares declined by 20.77% to $4.75. The market value of their outstanding shares is at $1.0 billion. </li>
<li>Safe &amp; Green Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGBX#NASDAQ">SGBX</a>) shares fell 14.49% to $1.06. The company's market cap stands at $7.5 million. </li>
<li>LanzaTech Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNZA#NASDAQ">LNZA</a>) shares declined by 11.62% to $0.23. The company's market cap stands at $52.9 million. </li>
<li>374Water (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCWO#NASDAQ">SCWO</a>) stock decreased by 8.03% to $0.44. The company's market cap stands at $63.2 million. </li>
<li>ATIF Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZBAI#NASDAQ">ZBAI</a>) shares decreased by 6.2% to $0.85. The market value of their outstanding shares is at $14.7 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CAPT

ELPW

EOSE

HTOO

LNZA

SCWO

SGBX

VCIG

ZBAI

12 Industrials Stocks Moving In Thursday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>HeartCore Enterprises (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTCR#NASDAQ">HTCR</a>) shares moved upwards by 24.2% to $0.72 during Thursday's pre-market session. The market value of their outstanding shares is at $15.9 million. </li>
<li>C3.ai (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AI#NYSE">AI</a>) shares moved upwards by 14.37% to $26.33. The market value of their outstanding shares is at $3.3 billion. As per the news, the Q4 earnings report came out yesterday. </li>
<li>Aurora Mobile (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JG#NASDAQ">JG</a>) shares increased by 9.65% to $11.95. The market value of their outstanding shares is at $71.5 million. As per the news, the Q1 earnings report came out today. </li>
<li>Boxlight (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOXL#NASDAQ">BOXL</a>) shares moved upwards by 9.35% to $2.22. The market value of their outstanding shares is at $4.9 million. </li>
<li>Exodus Movement (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/EXOD#AMEX">EXOD</a>) stock moved upwards by 9.33% to $28.36. The market value of their outstanding shares is at $817.7 million. </li>
<li>AMTD Digital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HKD#NYSE">HKD</a>) shares rose 9.18% to $2.14. The company's market cap stands at $672.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Signing Day Sports (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SGN#AMEX">SGN</a>) shares decreased by 14.6% to $1.87 during Thursday's pre-market session. The market value of their outstanding shares is at $6.7 million. </li>
<li>Actelis Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASNS#NASDAQ">ASNS</a>) shares fell 13.83% to $0.65. The company's market cap stands at $5.8 million. </li>
<li>SentinelOne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/S#NYSE">S</a>) stock decreased by 13.02% to $17.11. The company's market cap stands at $5.6 billion. The company's, Q1 earnings came out yesterday. </li>
<li>Alpha Modus Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMOD#NASDAQ">AMOD</a>) stock declined by 10.69% to $1.17. The market value of their outstanding shares is at $16.1 million. </li>
<li>HP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPQ#NYSE">HPQ</a>) stock declined by 9.19% to $24.7. The company's market cap stands at $23.2 billion. The company's, Q2 earnings came out yesterday. </li>
<li>MicroCloud Hologram (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOLO#NASDAQ">HOLO</a>) stock declined by 7.51% to $9.62. The market value of their outstanding shares is at $49.3 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMOD

ASNS

BOXL

EXOD

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

HTCR

12 Information Technology Stocks Moving In Thursday's Pre-Market Session

La Rosa Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRHC#NASDAQ">LRHC</a>) reported quarterly losses of $(5.86) per share. This is a 1574.29 percent decrease over losses of $(0.35) per share from the same period last year. The company reported $17.51 million in sales this quarter. This is a 33.81 percent increase over sales of $13.09 million the same period last year.

Earnings

LRHC

La Rosa Holdings Q1 EPS $(5.86) Down From $(0.35) YoY, Sales $17.51M Up From $13.09M YoY

TEVA

Teva Provides Updates Ahead Of Its Innovation and Strategy Day; Say sInnovative Medicines Franchise On Track To Exceed $5B By 2030, Reaffirms 2027 Financial Targets

Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUCY#NASDAQ">LUCY</a>, LUCYW))), the manufacturer of smart eyewear under the Lucyd&#xAE;, Lucyd Armor&#xAE;, Reebok&#xAE;, Eddie Bauer&#xAE; and Nautica&#xAE;&nbsp;brands, is pleased to announce a powerful new update to the Company's Lucyd app for iOS and Android. The Lucyd app was the first to enable voice access to ChatGPT in smart eyewear, and the Company believes these latest enhancements further advance its market position as a leader in smart eyewear. &nbsp;

LUCY

Innovative Eyewear Launches Major Update To Lucyd App For iOS And Android, Strengthening Its Leadership In Smart Eyewear With Enhanced Voice-Activated ChatGPT Integration Across Lucyd Brands

CCC's Digital and AI Solutions Support BMW Drivers After a Collision as the Number of Promotionally Priced OEM Parts Available to Repairers Triples
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcccis.com%2F&amp;esheet=54261813&amp;newsitemid=20250529221446&amp;lan=en-US&amp;anchor=CCC+Intelligent+Solutions+Inc.&amp;index=1&amp;md5=d65d9233be490c3115b92525d96d792e">CCC Intelligent Solutions Inc.</a> (CCC), a leading cloud platform provider powering the P&amp;C insurance economy, today announced that it was selected by BMW of North America to help enhance the post-collision experience for its drivers. By integrating CCC technology into its customer-facing digital experience, BMW now makes it easier for drivers in the U.S. to find and connect with certified repair centers, request photo estimates and gain early insight into repair costs. At the same time, the number of BMW certified parts available to repairers has been significantly expanded through CCC&#xAE; Parts, helping shops access competitively priced original BMW components.

CCCS

CCC Intelligent Solutions Chosen By BMW Of North America To Help Enhance Post-Collision Experience For Drivers

Management

KOPN

Kopin Announces CFO Rich Sneider To Retire And Will Stay In Role Till Successor Is Found

WIIM

Alzamend Neuro shares are trading higher after the company dosed the first patient in its Phase II clinical trial of AL001.

Estrella Immunopharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESLA#NASDAQ">ESLA</a>) ("Estrella" or the "Company"), a clinical stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS&#xAE; T-cell therapies to treat cancer and autoimmune diseases, today announced that the first patient has been dosed in the second cohort of its dose escalation study of Phase I/II STARLIGHT-1 trial for EB103, a CD19-redirected ARTEMIS&#xAE; T-cell therapy to treat patients with Advanced B-Cell Non-Hodgkin's Lymphomas (NHL).
The second cohort will evaluate EB103 at a higher dose level following a review of safety data from the first dose cohort. As previously announced, no dose-limiting toxicities (DLTs) or treatment-related serious adverse events (SAEs) were observed in the first cohort. The initiation of dosing in the second cohort reflects steady progress in Estrella's mission to complete Phase I of STARLIGHT-1.

ESLA

Estrella Immunopharma Announces First Patient Dosed In Second Cohort Of Dose Escalation Study Of Phase I/II STARLIGHT-1 Trial For EB103 To Treat Patients With Advanced B-Cell NHL

Partnership to develop rugged edge AI/ML compute solutions to improve cognitive dominance for U.S. Special Operations Forces
Agreement aligns with OSS' strategy to expand offerings and establish embedded relationships across the U.S. Department of Defense
One Stop Systems, Inc. ("OSS" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OSS#NASDAQ">OSS</a>), a leader in rugged Enterprise Class compute for artificial intelligence (AI), machine learning (ML) and sensor processing at the Edge, today announced that the Company has entered into a Cooperative Research and Development Agreement (CRADA) with U.S. Special Operations Command (USSOCOM) to create advanced, durable High Performance edge Computer (HPeC) solutions that can process vast amounts of data quickly and efficiently in the field.
Under the CRADA, OSS will demonstrate its current, cutting-edge AI and ML computing solutions designed specifically for rugged, edge environments to&nbsp;advance&nbsp;USSOCOM maritime platform performance and capabilities. The partnership leverages OSS' expertise in designing Enterprise Class compute systems that operate in extreme conditions such as harsh climates or remote locations. Solutions under development will support a strategic initiative of USSOCOM, which seeks to enhance the situational awareness, decision-making, and operational capabilities of special operations forces (SOF) in maritime operations. By leveraging AI and ML at the edge, USSOCOM aims to improve cognitive dominance—enabling warfighters to process information faster than their adversaries, to make more informed decisions, and to ultimately achieve mission objectives with greater precision.
"Our collaboration with USSOCOM will provide warfighters with more sophisticated and intelligent tools to improve their performance in increasingly complex and dynamic combat scenarios, thus reinforcing their competitive advantage on the battlefield," commented Robert Kalebaugh, OSS VP of Sales. "SOF's role within the U.S. Department of Defense continues to evolve across echelons, from man-worn to command center operations, and OSS is uniquely qualified to support the needs of U.S. Special Operation Forces."
"Today's announcement also reflects our multi-year strategy focused on expanding our offerings and establishing relationships across all branches of the U.S. Armed Forces. The USSOCOM CRADA represents an important pillar as we continue to forge a relationship with one of the most innovative commands within the Department of Defense. We believe the Armed Forces will accelerate the adaptation of these types of Enterprise Class architecture which OSS provides for AI/ML, sensor fusion and autonomy applications across maritime, land, air, and space domains," concluded Mr. Kalebaugh.

Contracts

One Stop Systems Enters Into Research And Development Agreement With U.S. Special Operations Command To Create Advanced, Durable High Performance Edge Computer Solutions That Can Process Vast Amounts Of Data Quickly And Efficiently In The Field

APDN

Applied DNA To Effect A 1-For-15 Reverse Stock Split On June 2, 2025

Biotech

General

Alzamend Neuro Doses First Patient In Phase II Clinical Trial of AL001

Easily one of the most dominant enterprises in recent memory is Palantir Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>). A big data analytics specialist, Palantir has been a massive beneficiary of the boom in artificial intelligence. Since the start of this year, PLTR stock has gained nearly 64% of equity value, easily leapfrogging the Nasdaq Composite index, which is down 1% during the same period. Still, valuation concerns impose a dark cloud over PLTR's prospects.
On the business front, it's difficult to argue against Palantir's dominance, especially in the realm of the defense industry. Recently, PLTR stock popped higher thanks to the Department of Defense awarding the underlying company a<a href="https://www.benzinga.com/25/05/45572000/palantir-stock-is-trading-higher-thursday-whats-going-on"> $795 million modification</a> to a contract for its Maven Smart System software licenses.
Initially, the deal was announced last year as a $480 million fixed, firm-price contract. However, with the modification, the terms of the agreement bring the total contract value up to nearly $1.28 billion. Fundamentally, the upgrade demonstrates the core influence that Palantir has achieved in its primary market.
In addition, Palantir is making significant inroads into the commercial sector. Notably, the company's Artificial Intelligence Platform (AIP) is gaining traction, allowing it to partner with major corporations. Indeed, Wedbush analyst Dan Ives believes that PLTR stock will command a<a href="https://www.benzinga.com/25/05/45232694/palantir-stock-shows-momentum-with-q1-results-ai-opportunity-analyst-says-generation-tech-name-worth-1-trillion-in-future"> trillion-dollar market capitalization</a> over the next three years.
Still, not everyone is convinced about Palantir's stratospheric run. One of the most notable criticisms centers on<a href="https://www.macrotrends.net/stocks/charts/PLTR/palantir-technologies/pe-ratio"> valuation</a>. As of this moment, PLTR stock trades at over 538-times trailing-12-month earnings. About a year ago, this metric was around 149 times – which was still a lofty figure. The anxiety, then, is that early investors will head for the exits.
This isn't just an empty sentiment. This year, the predominant transaction type among<a href="https://www.benzinga.com/quote/PLTR/insider-trades"> insider activity</a> for PLTR stock was sell orders, either for the equity or its options. To be fair, insiders sell stock for a variety of reasons, many of them mundane. Nevertheless, it's not the most encouraging sign when insiders – the folks that know the business the best – head for the exits.
The Direxion ETFs: While the trajectory of PLTR stock this year has been largely one-sided, there's more than enough room for skepticism – and that suits financial services provider Direxion perfectly. Thanks to its PLTR-focused bull and bear exchange-traded funds, traders can easily speculate on the tech specialist's fortunes (or misfortunes).
For the optimists, they may consider the Direxion Daily PLTR Bull 2X Shares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTU#NASDAQ">PLTU</a>), which seeks the daily investment results, before fees and expenses, of 200% of the performance of PLTR stock. Conversely, the pessimists may be intrigued by the Direxion Daily PLTR Bear 1X Shares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTD#NASDAQ">PLTD</a>), which tracks 100% of the inverse performance of the namesake equity.
Primarily, the main functionality of these specialized ETFs is to offer convenient mechanisms for speculation. Typically, those interested in utilizing leverage or engaging in short positions must trade options. While derivative financial instruments offer incredible flexibility, they're also complex vehicles with unique risk-reward profiles. With Direxion ETFs, the units can be bought and sold much like any other public security, thus easing the learning curve.
Still, there are serious risks to consider. First, both leveraged and inverse ETFs tend to be more volatile than standard bread-and-butter funds. Second, PLTU and PLTD were designed for exposure lasting no longer than one day. Holding onto these funds for longer than the recommended period may lead to value decay due to the daily compounding effect.
The PLTU ETF: Since the start of this year, the Direxion Daily PLTR Bull 2X Shares nearly doubled in value thanks to the robust performance of PLTR stock.
<ul class="wp-block-list">
<li>Currently, technical momentum in the PLTU ETF is robust, with the bull fund above both its 50-day moving average (DMA) and its 20-day exponential moving average (EMA).</li>
<li>One concern to note is that May's rising price action has been met with declining volume. Ideally, rising volume should confirm rising price, thus warranting caution.</li>
</ul>
<figure class="wp-block-image"><img loading="lazy" decoding="async" width="1037" height="618" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/29075921/image-382.png" alt="" class="wp-image-931425" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/29075921/image-382.png 1037w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/29075921/image-382-300x184.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/29075921/image-382-1024x628.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/29075921/image-382-768x471.png 768w" sizes="(max-width: 1037px) 100vw, 1037px" /></figure>
The PLTD ETF: Predictably, the year-to-date performance of the Direxion Daily PLTR Bear 1X Shares has been poor, with the bear fund losing more than 54%.
<ul class="wp-block-list">
<li>In a picture of contrasts, the PLTD ETF is conspicuously below both its 50 DMA and its 20 EMA, reflecting deep pessimism.</li>
<li>At the same time, the inverse fund is attempting to develop a baseline at the $10.50 level. If so, a quick reversal toward the $11 mark isn't out of the question.</li>
</ul>
<figure class="wp-block-image"><img loading="lazy" decoding="async" width="1036" height="635" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/29075921/image-382.png" alt="" class="wp-image-931426" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/29075921/image-382.png 1036w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/29075921/image-382-300x184.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/29075921/image-382-1024x628.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/29075921/image-382-768x471.png 768w" sizes="(max-width: 1036px) 100vw, 1036px" /></figure>
Featured image by <a href="https://pixabay.com/users/thedigitalartist-202249/?utm_source=link-attribution&amp;utm_medium=referral&amp;utm_campaign=image&amp;utm_content=7186533">Pete Linforth</a> from <a href="https://pixabay.com/illustrations/big-data-data-information-binary-7186533/">Pixabay</a>.

Long Ideas

Short Ideas

Technicals

Trading Ideas

ETFs

PLTD

PLTR

PLTU

Productivity Clashes With Premium Valuations For Direxion's PLTR-Focused Bull And Bear Funds

<ul>
<li>CC-42344 was shown to be highly active against the highly pathogenic 2024 Texas H5N1 avian influenza strain</li>
<li>The Company's virology study further confirmed the previous structural and in vitro data that revealed the binding of CC-42344 to PB2 protein of the 2024 H5N1 avian influenza virus</li>
</ul>
BOTHELL, Wash., May 29, 2025 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=a2lvSGEYfO0wnqCxWhGN5Th2eyiuG47RucIAbJQEGzvjuCfbXbv1Ec0_EkxdTb7h66djGR5DLGdfjb8IPoG_D23fZs9axyH_vboP8qCGanQ=">Cocrystal Pharma, Inc</a>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COCP#NASDAQ">COCP</a>) announces that a recent virology study showed its novel, broad-spectrum influenza PB2 inhibitor CC-42344 exhibits strong antiviral activity against the highly pathogenic H5N1 avian influenza A strain (A/Texas/37/2024).
On March 25, 2024, the highly pathogenic avian H5N1 influenza virus was confirmed in a dairy cow in Texas and has continued to spread widely in U.S. dairy cattle, causing a few human cases. There is concern that the H5N1 virus could adapt for human-to-human transmission and potentially result in an influenza pandemic. CC-42344 is a new investigational drug candidate for the treatment of pandemic and seasonal influenza infections. This inhibitor binds to a highly conserved active site of the PB2 protein and inhibits the viral replication process. The Company previously announced the structural and in vitro data of CC-42344 with the purified H5N1 PB2 protein.
The virology study utilized the highly pathogenic H5N1 avian strain (influenza A/Texas/37/2024) and was conducted to test antiviral activity of CC-42344 using Tamiflu&#xAE; as a reference inhibitor. The data showed that CC-42344 was highly potent against the H5N1 avian influenza virus (EC50, 0.003 µM), approximately 1,000-fold more potent, compared to a refence compound Tamiflu (EC50, 2.69 µM). CC-42344 is currently in development as an oral treatment for pandemic avian and seasonal influenza A infections with initial data showing a favorable safety and tolerability profile.

COCP

Cocrystal Pharma's Recent Virology Study Shows Broad-Spectrum Influenza PB2 Inhibitor CC-42344 Exhibits Strong Antiviral Activity Against Highly Pathogenic H5N1 Avian Influenza A Strain

Press Releases

Rush Street Interactive Expands Its Board With Appointment of Thomas Winter

Rush Street Interactive to Participate at Upcoming Investor Conference

BetRivers Welcomes Gambling Icon Phil Hellmuth as Brand Ambassador

Swinomish Indian Tribal Community Partners With Rush Street Interactive to Launch BetRivers Retail Sportsbook in Washington

Rush Street Interactive Announces Fourth Quarter and Year-End 2024 Earnings Release Date

Rush Street Interactive Announces Fourth Quarter 2024 and Full Year 2024 Results

Inspired Expands Global Partnership with Rush Street Interactive via RushBet in Mexico, Colombia, Peru and BetRivers in the U.S. State of Delaware

Rush Street Interactive Announces First Quarter 2025 Earnings Release Date

Rush Street Interactive Announces First Quarter 2025 Results and Reiterates Full Year Guidance

Rush Street Interactive Announces Initiative Supporting Increased Gaming Literacy For Teens

INSE

Accel Entertainment

PlayAGS

Ballys

Boyd Gaming

Codere Online Luxembourg, S.A. - Ordinary Shares

Codere Online Luxembourg

Churchill Downs, Incorporated - Common Stock

Churchill Downs

Canterbury Park Holding Corporation - Common Stock

Canterbury Park Holding

Caesars Entertainment, Inc. - Common Stock

Caesars Entertainment

DraftKings

Everi Holdings

Full House Resorts

Golden Entertainment, Inc. - Common Stock

Golden Entertainment

Genius Sports

International Game Technology Ordinary Shares

Intl Game Tech

Inspired Entertainment, Inc. - Common Stock

Inspired Entertainment

Light & Wonder

Las Vegas Sands

Monarch Casino & Resort, Inc. - Common Stock

Monarch Casino & Resort

MGM Resorts International

Melco Resorts & Entertainment Limited - American Depositary Shares

Melco Resorts and Enter

Studio City International Holdings Limited American depositary shares, each representing four Class A ordinary shares

Comments

Rush Street Interactive

뉴스

파트너 / 기고자

벤징가 글로벌